Boehringer Ingelheim: Christine Sakdalan and Mike Jablonski talk precision psychiatry

Power to the Patients

Apr 09 2025 | 00:40:32

00:00 / 00:40:32

Show Notes

In this episode of Power to the Patients, Boehringer Ingelheim leaders Christine Sakdalan and Mike Jablonski from discuss how precision psychiatry—using tools like biomarkers and neuroimaging—can personalize treatment for conditions like schizophrenia and depression. They highlight the importance of holistic care, digital therapeutics, and industry collaboration to address unmet needs and improve outcomes in mental health.

Other Episodes

Episode

October 03, 2023 • 00:44:42

Oncology trial strategy with Deb Kientop, VP Clinical Operations at Deka Biosciences

In today’s healthcare landscape, the term ‘patient-centric’ has been showing up more and more. It emphasizes the importance of considering the patient’s needs, experiences,...

Episode

December 11, 2023 • 00:30:24

Patient-informed clinical trial development with Victoria DiBiaso, VP & Global Head Patient Informed Development & Health Value Translation at Sanofi

Today’s episode features Victoria DiBiaso from Sanofi. Victoria provides a detailed analysis of patient-informed development and the critical importance of diversity and inclusion in...

Episode

August 14, 2025 • 00:56:17

Matthew Leoni, CMO of Merida Biosciences, on Navigating the Challenges and Opportunities in Neuroscience Drug Development

Brandon Li talks with Matt Leoni—former Senior VP of Global Clinical Development at Cerevel and now Chief Medical Officer at Merida Biosciences. Matt shares...